524743-24-6

Basic information

• Product Name: Benzoic acid, 4-[2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)ethyl]-, ethyl ester
• CAS NO: 524743-24-6
• Molecular Formula: C19H17NO4
• Molecular Weight: 323.348
• Mol File: 524743-24-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-[2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)ethyl]-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-[2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)ethyl]-, ethyl ester(524743-24-6)
• EPA Substance Registry System: Benzoic acid, 4-[2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)ethyl]-, ethyl ester(524743-24-6)

Safety Data

• Hazardous Substances Data: 524743-24-6(Hazardous Substances Data)

Upstream product

• 136918-14-4 phthalimide 
• 78254-55-4 ethyl 4-(2-hydroxyethyl)benzoate 
• 574-98-1 2-(2-bromoethyl)isoindoline-1,3-dione 
• 5798-75-4 Ethyl 4-bromobenzoate 
• 69395-13-7 4-(2-hydroxyethyl)benzonitrile 
• 308846-03-9 4-[2-(1,3-dioxoisoindolin-2-yl)ethyl]benzonitrile 
• 64-17-5 ethanol 

Downstream Products

• 714568-34-0 2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]-ethylamine 
• 1374416-64-4 C₃₅H₃₆N₄O₃S 
• 1374416-55-3 C₂₈H₂₈Cl₂N₄O₃S 
• 1374416-56-4 C₂₈H₂₈Cl₂N₄O₃S 
• 1374416-57-5 C₂₈H₂₈Cl₂N₄O₃S 
• 942613-38-9 2-{2-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-ethyl}-isoindole-1,3-dione 
• 77266-69-4 2-(4-carboethoxyphenyl)ethylamine 

Relevant articles and documents

Nickel-catalysed cross-electrophile coupling of aryl bromides and primary alkyl bromides

The structure of primary alkylated arenes plays an important role in the molecular action of drugs and natural products. The nickel/spiro-bidentate-pyox catalysed cross-electrophile coupling of aryl bromides and primary alkyl bromides was developed for th

5-AMIDINO-2-HYDROXYBENZENESULFONAMIDE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE SAME, MEDICINAL USE THEREOF AND INTERMEDIATES IN THE PRODUCTION THEREOF

The present invention relates to a 5-amidino-2-hydroxybenzenesulfonamide derivative represented by the general formula: wherein R1 is an optionally substituted lower alkyl group, an optionally substituted lower alkoxy group, an optionally substituted lower alkenyl group, a cycloalkyl group or a lower acyl group etc.; Q is a hydrogen atom or an optionally substituted lower alkyl group; and Z is a hydrogen atom or a hydroxy group etc., or a pharmaceutically acceptable salt thereof, which exert a potent and selective activated blood coagulation factor X inhibitory activity and is useful as an agent for the prevention or treatment of a disease occurred associating an activated blood coagulation factor X, a pharmaceutical composition comprising the same and an intermediate thereof. These compounds are useful as preventives or remedies for various diseases such as brain infarction, cerebral thrombosis, cerebral embolism, TIA, cerebral vascular jerk, Alzheimer's diseases, myocardial infarction, heart attack, heart failure, thrombosis, pulmonary infarction and pulmonary embolism.